Caitong International Asset Management’s ResMed RMD Stock Holding History

Caitong International Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$390	Sell	2 -2	-50%	-$415	﹤0.01%	1826
2026 Q1	$898	Buy	+4	New	+$997	﹤0.01%	1471
2025 Q4	–	Sell	-24	Closed	-$6.57K	–	2304
2025 Q3	$6.57K	Buy	+24	New	+$6.56K	﹤0.01%	1149
2025 Q2	–	Sell	-5	Closed	-$1.12K	–	2406
2025 Q1	$1.12K	Sell	5 -101	-95%	-$23.6K	﹤0.01%	1540
2024 Q4	$24.2K	Buy	+106	New	+$25.5K	0.02%	729

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Caitong International Asset Management's RMD Position: Q2 2026 in Review

Caitong International Asset Management reduced its ResMed (RMD) stake by 50% in Q2 2026, selling an estimated $415 and leaving 2 shares worth $390. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Caitong International Asset Management first reported a position in RMD in Q4 2024 and has held it in 5 quarters since. The position peaked at $24.2K in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Caitong International Asset Management held 2 shares of ResMed worth $390 as of Q2 2026.
Caitong International Asset Management sold 2 ResMed shares in Q2 2026, an estimated $415.
ResMed made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1826 holding.
Caitong International Asset Management first reported a position in ResMed in Q4 2024 and has held it in 5 quarters since.
Caitong International Asset Management's ResMed position peaked at $24.2K in Q4 2024.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.